Scientists track 140 ALS patients for clues in blood and spinal fluid
NCT ID NCT07312240
Summary
This study aims to better understand why ALS progresses differently in each person by tracking 140 patients for up to 3 years. Researchers will regularly collect blood and spinal fluid samples to measure biological markers while recording symptoms and disease progression. The goal is to find patterns that could help predict disease course and improve future treatment trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYOTROPHIC LATERAL SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Istituto Auxologico Italiano IRCCS
RECRUITINGMilan, Lombardy, 20149, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.